Delivery Order SPE2DB22D3004-SPE2DB25FRY93
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for Annovera vaginal rings, with a ceiling value of $6,710.26. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $3,637.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on July 25, 2025, with completion expected by July 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,014.46 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Annovera vaginal rings. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The award carries no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order valued at $1,810.98 to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,234.04 to AmerisourceBergen Drug Corp for Annovera vaginal rings, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order, indicating it flows from a larger indefinite delivery contract vehicle. The contraceptive product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,754.04 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This contract, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this contract demonstrates...
- The Defense Logistics Agency awarded a delivery order valued at $4,759.87 to AmerisourceBergen Drug Corp for Annovera vaginal rings under a firm fixed price contract. This award, issued on August 11, 2025, represents a non-competitive delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Annovera is a vaginal contraceptive ring indicated for prevention...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,976.98 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of Annovera vaginal rings. This contract has an ultimate completion date of August 19, 2024 and does not utilize a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for the provision...
- This is a $2,596.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ANNOVERA vaginal rings. The contract has an ultimate completion date of July 1, 2025 and is not set aside. Amerisourcebergen Drug Corp is the prime contractor and holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- This is a $3,294.06 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ANNOVERA vaginal rings. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen is an experienced federal contractor, holding a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRY93Delivery Order
The Defense Logistics Agency awarded a $2,570.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems through its comprehensive IDC vehicle, which enables the supply of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order represents one of numerous pharmaceutical procurement transactions the company executes under its prime IDV authority, demonstrating its established capability to meet federal medical supply requirements through competitive procurement processes and firm fixed pricing arrangements across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/12/25 |